The unique design of the AT LARA 829MP, developed via around 50,000 optical simulations, also induces less visual side effects than multifocal IOLs, making it attractive to patients that have an active lifestyle. Unlike traditional multifocal IOLs, EDoF lenses work by creating a single elongated focal point to enhance ‘range of vision’ or ‘depth of focus’.{{quote-A:R-W:450-I:2-Q:AT LARA offers patients a continuous range of functional vision for far to intermediate distances, with reduced risk of undesired halos or glare.-WHO:Kylee Hall, Zeiss medical division manager}}Zeiss medical division manager Ms Kylee Hall said there is an increasing dand for prium IOLs as many patients are not satisfied with having to wear glasses for everyday activities, which is often the case when using a conventional monofocal IOL.“AT LARA 829MP represents the latest advancent in cataract technology and expands Zeiss’ preloaded IOL portfolio to assist our customers in optimally addressing the challenges of surgical cataract and presbyopia correction,” Hall said.“More and more people want to enjoy exceptional visual performance as soon as possible after cataract surgery. We are enabling our customers to provide every single patient with the best visual perception possible. As many activities in our everyday lives require good vision in the intermediate range, AT LARA offers patients a continuous range of functional vision for far to intermediate distances, with reduced risk of undesired halos or glare.”An official launch for the IOL will take place in Lisbon at the European Society of Cataract and Refractive Surgeons (ESCRS) Congress in October; however, it is already commercially available and has been implanted more than 1,000 times.
Snow family donating $50m to glaucoma research at University of Sydney
The Snow Medical Research Foundation (Snow Medical) is launching the Snow Vision Accelerator in partnership with the University of Sydney, with...